Yin, Jianyong <br/><br/>
Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury.  [electronic resource] 

 -  Journal of cellular and molecular medicine  Dec 2017 
 - 3506-3514 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1582-4934 
<br/><br/><label>Standard No.: </label>10.1111/jcmm.13261  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--antagonists & inhibitors<br/>Acute Kidney Injury--genetics<br/>Animals<br/>Antithrombin III--pharmacology<br/>Collagen Type I--antagonists & inhibitors<br/>Disease Models, Animal<br/>Disease Progression<br/>Fibronectins--antagonists & inhibitors<br/>Fibrosis<br/>Gene Expression Regulation--drug effects<br/>Interleukin-1beta--antagonists & inhibitors<br/>Kidney--drug effects<br/>Macrophages--drug effects<br/>Male<br/>Nephrectomy<br/>Nitric Oxide Synthase Type II--antagonists & inhibitors<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reperfusion Injury--genetics<br/>Signal Transduction<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors